2016 | | Genetic polymorphisms in the Wnt/beta-catenin pathway genes as predictors of tumor development and survival in patients with hepatitis B virus-associated hepatocellular carcinoma | 김순선, 노충균, 신성재, 유병무, 이광재, 이기명, 정재연, 조성원, 조효정 |
2013 | | Genomic copy number alterations with transcriptional deregulation at 6p identify an aggressive HCC phenotype. | 강호철, 백은주, 우현구, 이수환, 최용준 |
2019 | | HDAC6 Suppresses Let-7i-5p to Elicit TSP1/CD47-Mediated Anti-Tumorigenesis and Phagocytosis of Hepatocellular Carcinoma | 왕희정, 은정우, 정재연 |
2021 | | Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma: Radiologic and clinical factors predictive of survival | 권요한, 김재근, 김진우, 원제환, 조효정, 허지미 |
2002 | | Hepatitis B virus X protein induced expression of interleukin 18 (IL-18): a potential mechanism for liver injury caused by hepatitis B virus (HBV) infection. | 조혜성 |
2001 | | Hepatitis B virus X protein induced expression of the Nur77 gene. | 조혜성 |
2004 | | Hepatitis B virus X protein modulates peroxisome proliferator-activated receptor gamma through protein-protein interaction. | 조혜성 |
2000 | | Hepatocellular carcinoma despite long-term survival in chronic tyrosinaemia I. | 한시훈 |
2023 | | Hepatocellular carcinoma incidence is decreasing in Korea but increasing in the very elderly | 김순선 |
1999 | | Hepatocellular carcinoma with tumor thrombi in the bile duct. | 김명욱, 김욱환, 김진홍, 왕희정 |
2012 | | Hepatocellular carcinoma: clinical and radiological findings in patients with chronic B viral hepatitis and chronic C viral hepatitis | 김영철 |
2015 | | High circulating microRNA-122 expression is a poor prognostic marker in patients with hepatitis B virus-related hepatocellular carcinoma who undergo radiofrequency ablation. | 김봉완, 김순선, 김재근, 노충균, 신성재, 왕희정, 이기명, 이제희, 정재연, 조성원, 조효정 |
2017 | | Higher serum interleukin-17A levels as a potential biomarker for predicting early disease progression in patients with hepatitis B virus-associated advanced hepatocellular carcinoma treated with sorafenib | 김보현, 김순선, 김재근, 신성재, 양민재, 유병무, 이광재, 이기명, 이제희, 임선교, 정재연, 조성원, 조효정, 황재철 |
2001 | | Human kinesin superfamily member 4 is dominantly localized in the nuclear matrix and is associated with chromosomes during mitosis. | 김완기, 이영미 |
2022 | | Hypomethylation-mediated upregulation of the WASF2 promoter region correlates with poor clinical outcomes in hepatocellular carcinoma | 강호철, 김순선, 은정우, 정재연, 조효정 |
1998 | | ICE-like protease (caspase) is involved in transforming growth factor beta1-mediated apoptosis in FaO rat hepatoma cell line. | 임인경, 최경숙 |
2010 | | Identification of a cholangiocarcinoma-like gene expression trait in hepatocellular carcinoma. | 우현구 |
2015 | | Identification of a mitochondrial defect gene signature reveals NUPR1 as a key regulator of liver cancer progression. | 왕희정, 우현구, 윤계순, 이영경 |
2016 | | Identification of NUCKS1 as a putative oncogene and immunodiagnostic marker of hepatocellular carcinoma | 김봉완, 김순선, 김영배, 왕희정, 정재연, 조성원 |
2018 | | Impact of nucleos(t)ide analog treatment on the development of malignancy in patients with chronic hepatitis B | 김순선, 박래웅, 양민재, 정재연, 조성원, 조효정 |
2013 | | Incidental focal hepatic mass. | 김영철, 김재근, 이제희 |
2024 | | Incidentally found parotid gland lesion in 18F-FDG PET/CT for staging evaluation of patients with hepatocellular carcinoma: remote possibility of metastatic tumor or second primary salivary gland malignancy | 조효정 |
2000 | | Increased expression of vascular endothelial growth factor and angiogenesis in the early stage of multistep hepatocarcinogenesis. | 김영배 |
2001 | | Increased proliferation activities of vascular endothelial cells and tumour cells in residual hepatocellular carcinoma following transcatheter arterial embolization. | 김영배 |
2021 | | Independent risk factors for hepatocellular carcinoma recurrence after direct-acting antiviral therapy in patients with chronic hepatitis C | 김순선, 박범희, 정재연, 조효정 |
2014 | | Influence of preoperative transcatheter arterial chemoembolization on gene expression in the HIF-1α pathway in patients with hepatocellular carcinoma. | 김봉완, 김영배, 왕희정 |
2017 | | Integrative analysis of genomic and epigenomic regulation of the transcriptome in liver cancer | 우현구, 윤사라, 지별아, 최지혜 |
2014 | | Inter-alpha-trypsin inhibitor heavy chain H4 as a diagnostic and prognostic indicator in patients with hepatitis B virus-associated hepatocellular carcinoma | 김순선, 신성재, 안선주, 유병무, 이기명, 정재연, 조성원, 조효정 |
2012 | | Interleukin-1ß and interleukin-1 receptor accessory protein gene polymorphisms are associated with persistent hepatitis B virus infection | 김순선, 정재연, 조성원 |
2015 | | Interleukin-8 level as a prognostic marker in patients with hepatitis B virus-associated hepatocellular carcinoma treated with transarterial chemoembolization. | 강대용, 김순선, 김재근, 박주한, 신성재, 원제환, 유병무, 이기명, 이제희, 정재연, 조성원, 조효정 |
2000 | | Intraportal insulin therapy after partial hepatectomy for hepatoma patients with insulinopenia. | 김명욱, 김욱환, 왕희정 |
2018 | | Keratin 19 Expression in Hepatocellular Carcinoma Is Regulated by Fibroblast-Derived HGF via a MET-ERK1/2-AP1 and SP1 Axis | 우현구, 최지혜 |
2017 | | Lactate-mediated mitoribosomal defects impair mitochondrial oxidative phosphorylation and promote hepatoma cell invasiveness | 권소미, 윤계순, 이영경 |
2019 | | Lactic acidosis caused by repressed lactate dehydrogenase subunit B expression down-regulates mitochondrial oxidative phosphorylation via the pyruvate dehydrogenase (PDH)-PDH kinase axis | 권소미, 윤계순, 이영경, 홍선미 |
2020 | | Liver stiffness in magnetic resonance elastography is prognostic for sorafenib-treated advanced hepatocellular carcinoma | 김보현, 김순선, 김재근, 이제희, 정재연, 조효정, 허지미 |
2020 | | Liver stiffness measured by MR elastography is a predictor of early HCC recurrence after treatment | 김보현, 김순선, 김재근, 은정우, 이제희, 정재연, 조효정, 허지미 |
2018 | | Liver volume-based prediction model stratifies risks for hepatocellular carcinoma in chronic hepatitis B patients on surveillance | 김순선, 정재연 |
2017 | | Low levels of circulating microRNA-26a/29a as poor prognostic markers in patients with hepatocellular carcinoma who underwent curative treatment | 강대용, 김보현, 김봉완, 김순선, 김재근, 신성재, 양민재, 왕희정, 이기명, 이제희, 정재연, 조성원, 조효정, 황재철 |
2015 | | Low serum interleukin-6 levels as a predictive marker of recurrence in patients with hepatitis B virus related hepatocellular carcinoma who underwent curative treatment. | 김순선, 김재근, 박주한, 왕희정, 정재연, 조성원, 조효정 |
2022 | | Lung and lymph node metastases from hepatocellular carcinoma: Comparison of pathological aspects | 우현구 |
2020 | | Management of liver diseases during the pandemic of coronavirus disease-19 | 김순선 |
2015 | | MET is a predictive factor for late recurrence but not for overall survival of early stage hepatocellular carcinoma. | 고영화 |
2014 | | MicroRNA-196A-2 polymorphisms and hepatocellular carcinoma in patients with chronic hepatitis B | 정재연, 조성원 |
2019 | | Mitochondria ubiquitin ligase, MARCH5 resolves hepatitis B virus X protein aggregates in the liver pathogenesis | NGUYEN, THI KIM OANH, 이호수, 조미영, 조혜성 |
2015 | | Mitochondrial Respiratory Dysfunction Induces Claudin-1 Expression via Reactive Oxygen Species-mediated Heat Shock Factor 1 Activation, Leading to Hepatoma Cell Invasiveness. | 변해옥, 왕희정, 윤계순, 이영경 |
2020 | | MLH1 single-nucleotide variant in circulating tumor DNA predicts overall survival of patients with hepatocellular carcinoma | 김순선, 우현구, 은정우, 정재연, 조효정, 최지혜 |
2023 | | Molecular and radiopathologic spectrum between HCC and intrahepatic cholangiocarcinoma | 우현구 |
2021 | | MRPS31 loss is a key driver of mitochondrial deregulation and hepatocellular carcinoma aggressiveness | 박태준, 우현구, 윤계순, 이영경 |
2018 | | Multiplatform Genomic Roadmap of Hepatocellular Carcinoma: A Matter of Molecular Heterogeneity | 우현구 |
2017 | | Mutations acquired by hepatocellular carcinoma recurrence give rise to an aggressive phenotype | 권소미, 왕희정, 우현구 |
2016 | | Opposite roles of cannabinoid receptors 1 and 2 in hepatocarcinogenesis | 조성원 |
2021 | | Outcomes after liver transplantation in korea: Incidence and risk factors from korean transplantation registry | 김봉완 |
2012 | | Overexpression of renal tumor antigen is associated with tumor invasion and poor prognosis of hepatocellular carcinoma | 왕희정 |
2017 | | Plasma micoRNA-122 as a predictive marker for treatment response following transarterial chemoembolization in patients with hepatocellular carcinoma | 김순선, 김진우, 노충균, 신성재, 양민재, 원제환, 이기명, 정재연, 조성원, 조효정, 지재훈 |
2018 | | Plasma MicroRNA-21, 26a, and 29a-3p as Predictive Markers for Treatment Response Following Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma | 김보현, 김순선, 김재근, 김진우, 김현지, 원제환, 이제희, 정재연, 조성원, 조효정 |
2013 | | Polymorphisms near interleukin 28B gene are not associated with hepatitis B virus clearance, hepatitis B e antigen clearance and hepatocellular carcinoma occurrence. | 정재연, 조성원 |
2022 | | Prediction of Decompensation and Death in Advanced Chronic Liver Disease Using Deep Learning Analysis of Gadoxetic Acid-Enhanced MRI | 허수빈 |
2020 | | Predictive score for hepatocellular carcinoma after hepatitis B e antigen loss in patients treated with entecavir or tenofovir | 김순선, 정재연 |
2004 | | Primary liver carcinoma of intermediate (hepatocyte-cholangiocyte) phenotype. | 김영배 |
2014 | | Profiling of exome mutations associated with progression of HBV-related hepatocellular carcinoma. | 김순선, 안선주, 우현구, 정재연, 조성원, 조효정 |